Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

95
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
95
Teratogenicity01:07

Teratogenicity

3.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

101
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
101
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

1.7K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.7K
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

98
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
98
Birth Control Methods01:22

Birth Control Methods

5.5K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What reproductive follow-up for adolescent and young women after cancer? A review.

Reproductive biomedicine online·2024
Same author

French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.

La Revue de medecine interne·2023
Same author

[Potential teratogenicity of modafinil - Conflicting evidence, need for research].

Gynecologie, obstetrique, fertilite & senologie·2023
Same author

A promising treatment to optimize delivery management in a pregnant woman with inherited thrombocytopenia: thrombopoietin-receptor agonist administration.

International journal of obstetric anesthesia·2022
Same author

Comment on "Maternal use of fluconazole and congenital malformations in the progeny: A meta-analysis of the literature".

Reproductive toxicology (Elmsford, N.Y.)·2021
Same author

Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same journal

[Environmental, Organizational, and Economic Impact of Cesarean Section Kits].

Gynecologie, obstetrique, fertilite & senologie·2026
Same journal

[Usefulness of routine fetal echocardiography in pregnancies with pre-existing maternal diabetes.]

Gynecologie, obstetrique, fertilite & senologie·2026
Same journal

[Assessing and improving post-therapeutic surveillance of precancerous cervical lesions in Reunion Island].

Gynecologie, obstetrique, fertilite & senologie·2026
Same journal

[Uterine Fibroid Myolysis: Outcomes and Quality of Life].

Gynecologie, obstetrique, fertilite & senologie·2026
Same journal

[Metformin for the prevention of hyperemesis gravidarum: From a GDF15-based rationale to early clinical evidence].

Gynecologie, obstetrique, fertilite & senologie·2026
Same journal

[From exclusion to responsible inclusion: Rethinking pregnant women in clinical research].

Gynecologie, obstetrique, fertilite & senologie·2026
See all related articles

Related Experiment Video

Updated: Dec 1, 2025

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.0K

[Methotrexate: How long between administration and conception?]

E Elefant1

  • 1Centre de référence sur les agents tératogènes (CRAT), DMU ESPRIT, épidémiologie et biostatistique, santé publique, pharmacie, pharmacologie, recherche, information médicale, thérapeutique et médicaments, GHU APHP Sorbonne Université, site Trousseau 26, avenue Dr-Netter, 75571 Paris cedex 12, France.

Gynecologie, Obstetrique, Fertilite & Senologie
|November 9, 2020
PubMed
Summary
This summary is machine-generated.

Women of childbearing age can conceive during the first menstrual cycle after stopping methotrexate. Current guidelines on waiting periods are inconsistent and may unnecessarily delay pregnancy for patients using methotrexate.

Keywords:
ConceptionDélaiEliminationGrossesseMethotrexateMéthotrexatePeriodPregnancy

More Related Videos

Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

23.3K
Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry
08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

13.3K

Related Experiment Videos

Last Updated: Dec 1, 2025

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.0K
Human Blastocyst Biopsy and Vitrification
10:59

Human Blastocyst Biopsy and Vitrification

Published on: July 26, 2019

23.3K
Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry
08:59

Identification Of Erythromyeloid Progenitors And Their Progeny In The Mouse Embryo By Flow Cytometry

Published on: July 17, 2017

13.3K

Area of Science:

  • Reproductive medicine
  • Pharmacology
  • Women's health

Background:

  • Methotrexate is frequently prescribed for non-cancerous conditions in women of childbearing potential.
  • Indications include chronic autoimmune diseases (psoriasis, rheumatoid arthritis, IBD) and acute conditions (ectopic pregnancy).
  • Current recommendations for discontinuing methotrexate before conception show significant variability.

Purpose of the Study:

  • To analyze objective evidence regarding the optimal timing for conception after methotrexate cessation.
  • To evaluate the necessity of prolonged waiting periods before attempting pregnancy.
  • To provide evidence-based guidance for managing methotrexate use in women desiring pregnancy.

Main Methods:

  • Systematic review of available objective evidence.
  • Analysis of pharmacokinetic and pharmacodynamic data of methotrexate.
  • Evaluation of clinical outcomes related to conception timing after methotrexate withdrawal.

Main Results:

  • Evidence does not support unnecessarily extending the period after methotrexate cessation before conception.
  • Conception is feasible within the first menstrual cycle after stopping the medication.
  • Prolonged waiting periods are not scientifically justified based on current data.

Conclusions:

  • The current variability in recommended waiting times for conception after methotrexate cessation is not evidence-based.
  • Women of childbearing age can be advised that conceiving in the first menstrual cycle post-methotrexate is possible.
  • Clinical practice should be updated to reflect the shorter, evidence-supported interval, reducing unnecessary delays to pregnancy.